Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30:R921–R925. https://doi.org/10.1016/j.cub.2020.06.081
Article CAS PubMed PubMed Central Google Scholar
Blake JA, Harris MA (2008) The Gene Ontology (GO) project: structured vocabularies for molecular biology and their application to genome and expression analysis. Curr Protoc Bioinformatics Chapter 7:721–729. https://doi.org/10.1002/0471250953.bi0702s00
Borden KL (1998) RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem Cell Biol 76:351–358. https://doi.org/10.1139/bcb-76-2-3-351
Article CAS PubMed Google Scholar
Cao J, Su B, Peng R, Tang H, Tu D, Tang Y, Zhou J, Jiang G, Jin S, Wang Q, Wang A, Liu R, Deng Q, Zhang C, Bai D (2022) Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma. J Gastrointest Oncol 13:1942–1958. https://doi.org/10.21037/jgo-22-619
Article PubMed PubMed Central Google Scholar
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S (2017) UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia 19:649–658. https://doi.org/10.1016/j.neo.2017.05.002
Article CAS PubMed PubMed Central Google Scholar
Chen C, Wang Z, Ding Y, Qin Y (2023) Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol 10(14):1133308. https://doi.org/10.3389/fimmu.2023.1133308
Chiossone L, Dumas PY, Vienne M, Vivier E (2018) Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol 18:671–688. https://doi.org/10.1038/s41577-018-0061-z
Article CAS PubMed Google Scholar
Chung YL, Wu ML (2016) Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen. Oncotarget 7:28393–28407. https://doi.org/10.18632/oncotarget.8613
Article PubMed PubMed Central Google Scholar
Couri T, Pillai A (2019) Goals and targets for personalized therapy for HCC. Hepatol Int 13:125–137. https://doi.org/10.1007/s12072-018-9919-1
Cui X, Lin Z, Chen Y, Mao X, Ni W, Liu J, Zhou H, Shan X, Chen L, Lv J, Shen Z, Duan C, Hu B, Ni R (2016) Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem 421:127–137. https://doi.org/10.1007/s11010-016-2793-z
Article CAS PubMed Google Scholar
Dai W, Wang J, Wang Z, Xiao Y, Li J, Hong L, Pei M, Zhang J, Yang P, Wu X, Tang W, Jiang X, Jiang P, Xiang L, Li A, Lin J, Liu S, Wang J (2021) Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma. Front Oncol 11:767644. https://doi.org/10.3389/fonc.2021.767644
Article CAS PubMed PubMed Central Google Scholar
de Silva S, Wu L (2011) TRIM5 acts as more than a retroviral restriction factor. Viruses 3:1204–1209. https://doi.org/10.3390/v3071204
Article CAS PubMed PubMed Central Google Scholar
Deng L, Meng T, Chen L, Wei W, Wang P (2020) The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther 5:11. https://doi.org/10.1038/s41392-020-0107-0
Article CAS PubMed PubMed Central Google Scholar
Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11–22. https://doi.org/10.1038/nrc1252
Article CAS PubMed Google Scholar
Fan W, Du F, Liu X (2019) TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3beta-dependent Wnt/beta-catenin signaling. Eur J Pharmacol 850:109–117. https://doi.org/10.1016/j.ejphar.2019.01.054
Article CAS PubMed Google Scholar
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314. https://doi.org/10.1016/S0140-6736(18)30010-2
Guo P, Qiu Y, Ma X, Li T, Ma X, Zhu L, Lin Y, Han L (2018) Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis. Exp Cell Res 368:59–66. https://doi.org/10.1016/j.yexcr.2018.04.013
Article CAS PubMed Google Scholar
Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, Wang H, Li T, Wang C (2023) TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res 51:D1425–D1431. https://doi.org/10.1093/nar/gkac959
Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7. https://doi.org/10.1186/1471-2105-14-7
Article PubMed PubMed Central Google Scholar
Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252–259. https://doi.org/10.1097/01.sla.0000171307.37401.db
Article PubMed PubMed Central Google Scholar
Hatakeyama S (2017) TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis. Trends Biochem Sci 42:297–311. https://doi.org/10.1016/j.tibs.2017.01.002
Article CAS PubMed Google Scholar
Hatanaka T, Yata Y, Naganuma A, Kakizaki S (2023) Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy. Cancers (Basel) 15. https://doi.org/10.3390/cancers15061798
Herquel B, Ouararhni K, Martianov I, Le Gras S, Ye T, Keime C, Lerouge T, Jost B, Cammas F, Losson R, Davidson I (2013) Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA. Nat Struct Mol Biol 20:339–346. https://doi.org/10.1038/nsmb.2496
Article CAS PubMed Google Scholar
Hu X, Tang Z, Ma S, Yu Y, Chen X, Zang G (2019) Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6/p38 pathway. Biochem Biophys Res Commun 511:889–895. https://doi.org/10.1016/j.bbrc.2019.02.001
Article CAS PubMed Google Scholar
Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R (2023) Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol 20:37–49. https://doi.org/10.1038/s41575-022-00688-6
Iglesias-Escudero M, Arias-González N, Martínez-Cáceres E (2023) Regulatory cells and the effect of cancer immunotherapy. Mol Cancer 422(1):26. https://doi.org/10.1186/s12943-023-01714-0
Jiang J, Yu C, Chen M, Tian S, Sun C (2015) Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/beta-catenin signaling. Biochem Biophys Res Commun 464:1120–1127. https://doi.org/10.1016/j.bbrc.2015.07.089
Article CAS PubMed Google Scholar
Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27–30. https://doi.org/10.1093/nar/28.1.27
Article CAS PubMed PubMed Central Google Scholar
Khetchoumian K, Teletin M, Tisserand J, Mark M, Herquel B, Ignat M, Zucman-Rossi J, Cammas F, Lerouge T, Thibault C, Metzger D, Chambon P, Losson R (2007) Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat Genet 39:1500–1506. https://doi.org/10.1038/ng.2007.15
Article CAS PubMed Google Scholar
Koh CH, Lee S, Kwak M, Kim BS, Chung Y (2023) CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med 55(11):2287–2299. https://doi.org/10.1038/s12276-023-01105-x
Article CAS PubMed PubMed Central Google Scholar
Koo SY, Park EJ, Noh HJ, Jo SM, Ko BK, Shin HJ, Lee CW (2023) Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism. Int J Mol Sci 24. https://doi.org/10.3390/ijms24098441
Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559. https://doi.org/10.1186/1471-2105-9-559
Article CAS PubMed PubMed Central Google Scholar
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS (2017) TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res 77:e108–e110. https://doi.org/10.1158/0008-5472.CAN-17-0307
Article CAS PubMed PubMed Central Google Scholar
Li X, Shao C, Shi Y, Han W (2018) Lessons learned from the blockade of immune checkpoints in cancer immunotherapy. J Hematol Oncol 11:31. https://doi.org/10.1186/s13045-018-0578-4
Article CAS PubMed PubMed Central Google Scholar
Li Q, Han J, Yang Y, Chen Y (2022) PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front Immunol 13:1070961.
留言 (0)